Search research articles
Contact Us
Filters
Showing results (121-130 of 143) with videos related to
Page
of 15
Sort By:
Clinical & Translational Immunology
|
February 13, 2026
The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients
Fredrika Hellgren, Rodrigo Arcoverde Cerveira, Gustaf Lindgren, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Egle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.
The Journal of Infectious Diseases
|
February 29, 2024
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
Benedikt Strunz, Christopher Maucourant, Adi Mehta, et al.
Journal of Hepatology
|
May 11, 2024
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial
Heiner Wedemeyer, Soo Aleman, Maurizia Brunetto, et al.
Science Translational Medicine
|
July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R Müller, Takuya Sekine, Darya Trubach, et al.
Nature Immunology
|
April 30, 2025
Identification of soluble biomarkers that associate with distinct manifestations of long COVID
Yu Gao, Curtis Cai, Sarah Adamo, et al.
JHEP Reports : Innovation in Hepatology
|
May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort
Sabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
Journal of Hepatology
|
October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Science Immunology
|
August 23, 2020
Natural killer cell immunotypes related to COVID-19 disease severity
Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, et al.
Ebiomedicine
|
December 3, 2021
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Peter Bergman, Ola Blennow, Lotta Hansson, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 143) with videos related to
Sort By:
Page
of 15
Clinical & Translational Immunology
|
February 13, 2026
The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients
Fredrika Hellgren, Rodrigo Arcoverde Cerveira, Gustaf Lindgren, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Egle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.
The Journal of Infectious Diseases
|
February 29, 2024
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
Benedikt Strunz, Christopher Maucourant, Adi Mehta, et al.
Journal of Hepatology
|
May 11, 2024
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial
Heiner Wedemeyer, Soo Aleman, Maurizia Brunetto, et al.
Science Translational Medicine
|
July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R Müller, Takuya Sekine, Darya Trubach, et al.
Nature Immunology
|
April 30, 2025
Identification of soluble biomarkers that associate with distinct manifestations of long COVID
Yu Gao, Curtis Cai, Sarah Adamo, et al.
JHEP Reports : Innovation in Hepatology
|
May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort
Sabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
Journal of Hepatology
|
October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Science Immunology
|
August 23, 2020
Natural killer cell immunotypes related to COVID-19 disease severity
Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, et al.
Ebiomedicine
|
December 3, 2021
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Peter Bergman, Ola Blennow, Lotta Hansson, et al.
Page
of 15